{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:29:48Z","timestamp":1792114188429,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Jining Key Research and Development Plan","award":["2023JNZC139"],"award-info":[{"award-number":["2023JNZC139"]}]},{"name":"the Le Ling Leading Research Program Research Fund Project","award":["60"],"award-info":[{"award-number":["60"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-025-05917-w","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T03:30:34Z","timestamp":1753932634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A retrospective cohort study using machine learning to predict coronary artery lesions in children with Kawasaki disease"],"prefix":"10.1186","volume":"25","author":[{"given":"Yanan","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"5917_CR1","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/INF.0000000000002793","volume":"39","author":"GB Kim","year":"2020","unstructured":"Kim GB, Eun LY, Han JW, Kim SH, Yoon KL, Han MY, et al. Epidemiology of Kawasaki disease in South Korea: a nationwide survey 2015\u20132017. Pediatr Infect Dis J. 2020;39:1012\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"5917_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","volume":"225","author":"R Ae","year":"2020","unstructured":"Ae R, Makino N, Kosami K, Kuwabara M, Matsubara Y, Nakamura Y. Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017\u20132018. J Pediatr. 2020;225:23\u20139.","journal-title":"J Pediatr"},{"key":"5917_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2188\/jea.JE20190065","volume":"30","author":"LP Xie","year":"2020","unstructured":"Xie LP, Yan WL, Huang M, Huang MR, Chen S, Huang GY, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2013 through 2017. J Epidemiol. 2020;30:429\u201335.","journal-title":"J Epidemiol"},{"key":"5917_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2188\/jea.JE20110131","volume":"22","author":"R Uehara","year":"2012","unstructured":"Uehara R, Belay ED. Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol. 2012;22:79\u201385.","journal-title":"J Epidemiol"},{"key":"5917_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjpo-2024-002650","author":"C Gong","year":"2024","unstructured":"Gong C, Liu K, Li B, Li Y, Gao H, Wang Z, Fu Y, Gao L, Hu L, Wang Y, Wang M, Zhao B, Liu X. Analysis and validation of clinical subgroups of Kawasaki disease in children in China: a retrospective study. BMJ Paediatr Open. 2024. https:\/\/doi.org\/10.1136\/bmjpo-2024-002650.","journal-title":"BMJ Paediatr Open"},{"issue":"7","key":"5917_CR6","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/ped.14242","volume":"62","author":"Y Nomura","year":"2020","unstructured":"Nomura Y, Yashiro M, Masuda K, et al. Treatment change and coronary artery abnormality in incomplete Kawasaki disease. Pediatr Int. 2020;62(7):779\u201384.","journal-title":"Pediatr Int"},{"key":"5917_CR7","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y, et al. JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease. Circ J. 2020;84:1348\u2013407.","journal-title":"Circ J"},{"key":"5917_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jaad.2013.06.040","volume":"69","author":"S Bayers","year":"2013","unstructured":"Bayers S, Shulman ST, Paller AS. Kawasaki disease: part II. complications and treatment. J Am Acad Dermatol. 2013;69:513.","journal-title":"J Am Acad Dermatol"},{"key":"5917_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM198608073150601","volume":"315","author":"JW Newburger","year":"1986","unstructured":"Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986;315:341\u20137.","journal-title":"N Engl J Med"},{"key":"5917_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","volume":"27","author":"R Uehara","year":"2008","unstructured":"Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J. 2008;27:155\u201360.","journal-title":"Pediatr Infect Dis J"},{"key":"5917_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41\u201355.","journal-title":"Biometrika"},{"issue":"4","key":"5917_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.5152\/TurkArchPediatr.2024.24076","volume":"59","author":"M G\u00fcl\u015fen","year":"2024","unstructured":"G\u00fcl\u015fen M, Yal\u00e7\u0131n SS. Fostering tomorrow: uniting artificial intelligence and social pediatrics for comprehensive child well-being. Turk Arch Pediatr. 2024;59(4):345\u201352.","journal-title":"Turk Arch Pediatr"},{"key":"5917_CR13","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American heart association. Circulation. 2017;135:e927\u201399.","journal-title":"Circulation"},{"key":"5917_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpeds.2017.03.025","volume":"185","author":"AP Salgado","year":"2017","unstructured":"Salgado AP, Ashouri N, Berry EK, et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease. J Pediatr. 2017;185:112\u2013e61.","journal-title":"J Pediatr"},{"key":"5917_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/archdischild-2018-314967","volume":"104","author":"SA Cameron","year":"2019","unstructured":"Cameron SA, Carr M, Pahl E, DeMarais N, Shulman ST, Rowley AH. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease. Arch Dis Child. 2019;104:451\u20135.","journal-title":"Arch Dis Child"},{"key":"5917_CR16","doi-asserted-by":"publisher","first-page":"153208","DOI":"10.1016\/j.phymed.2020.153208","volume":"70","author":"B Tang","year":"2020","unstructured":"Tang B, Lo HH, Lei C, et al. Adjuvant herbal therapy for targeting susceptibility genes to Kawasaki disease: an overview of epidemiology, pathogenesis, diagnosis and pharmacological treatment of Kawasaki disease. Phytomedicine. 2020;70:153208.","journal-title":"Phytomedicine"},{"key":"5917_CR17","doi-asserted-by":"publisher","first-page":"624802","DOI":"10.3389\/fimmu.2021.624802","volume":"12","author":"T Kitoh","year":"2021","unstructured":"Kitoh T, Ohara T, Muto T, et al. Increased pentraxin 3 levels correlate with IVIG responsiveness and coronary artery aneurysm formation in Kawasaki disease. Front Immunol. 2021;12:624802.","journal-title":"Front Immunol"},{"key":"5917_CR18","doi-asserted-by":"publisher","first-page":"520865","DOI":"10.1100\/2012\/520865","volume":"2012","author":"HC Kuo","year":"2012","unstructured":"Kuo HC, Chao MC, Hsu YW, et al. CD40 gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population. Sci World J. 2012;2012:520865.","journal-title":"Sci World J"},{"key":"5917_CR19","first-page":"324","volume":"37","author":"H Qiu","year":"2020","unstructured":"Qiu H, Jia C, Wang Z, et al. Prognosis and risk factors of coronary artery lesions before immunoglobulin therapy in children with Kawasaki disease. Balkan Med J. 2020;37:324\u20139.","journal-title":"Balkan Med J"},{"key":"5917_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.","journal-title":"Front Immunol"},{"key":"5917_CR21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jped.2023.02.005","volume":"99","author":"S Shuai","year":"2023","unstructured":"Shuai S, Zhang H, Zhang R, et al. Prediction of coronary artery lesions based on C-reactive protein levels in children with Kawasaki disease: a retrospective cohort study. J Pediatr. 2023;99:406\u201312.","journal-title":"J Pediatr"},{"key":"5917_CR22","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1007\/s00296-019-04375-9","volume":"39","author":"A Nandi","year":"2019","unstructured":"Nandi A, Pal P, Basu S. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study. Rheumatol Int. 2019;39:1797\u2013801.","journal-title":"Rheumatol Int"},{"key":"5917_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/RHU.0000000000001925","volume":"29","author":"R Wu","year":"2023","unstructured":"Wu R, Jiang W, Sun Y, et al. Indicators of oxidative stress in the prediction of coronary artery lesions in patients with Kawasaki disease. J Clin Rheumatol. 2023;29:126\u201331.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"5917_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/s12887-024-04608-2","volume":"24","author":"Y Tang","year":"2024","unstructured":"Tang Y, Liu Y, Du Z, Wang Z, Pan S. Prediction of coronary artery lesions in children with Kawasaki syndrome based on machine learning. BMC Pediatr. 2024;24(1):158.","journal-title":"BMC Pediatr"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05917-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05917-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05917-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T08:20:44Z","timestamp":1757319644000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05917-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5917"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05917-w","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"8 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the Helsinki Declaration, the Ethics Committee of Affiliated Hospital of Qingdao University approved this single center cross-sectional study. The Institutional Review Board (IRB) has abandoned the necessity of agreeing to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"583"}}